Wells Fargo downgraded HCA Healthcare (HCA) to Underweight from Equal Weight with a price target of $320, down from $400. The firm cut out-year estimates for the hospitals to reflect its assumption that enhanced exchange subsidies will expire. Current policy and fiscal uncertainty warrant lower multiples in the group, the analyst tells investors in a research note. Wells sees the extension of enhanced exchange subsidies as unlikely following the Republican sweep. Assuming the expiration of enhanced subsidies was a 50% probability before the election and a 100% probability now, the group multiples are little changed since the election, contends Wells. It expects “uncertainty to remain high for some time.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz
- HCA Healthcare downgraded to Market Perform from Outperform at Raymond James
- HCA Healthcare exec Whalen sells 1,474 common shares
- HCA Healthcare price target lowered to $392 from $396 at Barclays
- HCA Healthcare price target raised to $400 from $395 at Wells Fargo